BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21034328)

  • 1. Effects of lycopene on proliferation and death of canine osteosarcoma cells.
    Wakshlag JJ; Balkman CE
    Am J Vet Res; 2010 Nov; 71(11):1362-70. PubMed ID: 21034328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma.
    Dimopoulou M; Kirpensteijn J; Moens H; Kik M
    Vet Surg; 2008 Jul; 37(5):466-71. PubMed ID: 18986314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.
    Wolfesberger B; Tonar Z; Gerner W; Skalicky M; Heiduschka G; Egerbacher M; Thalhammer JG; Walter I
    Res Vet Sci; 2010 Feb; 88(1):94-100. PubMed ID: 19665156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of dihydroartemisinin in canine osteosarcoma cell lines.
    Hosoya K; Murahari S; Laio A; London CA; Couto CG; Kisseberth WC
    Am J Vet Res; 2008 Apr; 69(4):519-26. PubMed ID: 18380584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft.
    Sottnik JL; Hansen RJ; Gustafson DL; Dow SW; Thamm DH
    Vet Comp Oncol; 2011 Jun; 9(2):118-30. PubMed ID: 21569197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of sulforaphane on canine osteosarcoma proliferation and invasion.
    Rizzo VL; Levine CB; Wakshlag JJ
    Vet Comp Oncol; 2017 Sep; 15(3):718-730. PubMed ID: 27045198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells.
    Lee DS; Lee MK; Kim JH
    Anticancer Res; 2009 Dec; 29(12):5039-44. PubMed ID: 20044614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative radiotherapy with electrons of appendicular osteosarcoma in 54 dogs.
    Mueller F; Poirier V; Melzer K; Nitzl D; Roos M; Kaser-Hotz B
    In Vivo; 2005; 19(4):713-6. PubMed ID: 15999538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterisation of cancer stem cells from canine osteosarcoma.
    Wilson H; Huelsmeyer M; Chun R; Young KM; Friedrichs K; Argyle DJ
    Vet J; 2008 Jan; 175(1):69-75. PubMed ID: 17851099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells.
    Wolfesberger B; Walter I; Hoelzl C; Thalhammer JG; Egerbacher M
    Res Vet Sci; 2006 Jun; 80(3):308-16. PubMed ID: 16182328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of canine osteosarcoma for limb preservation using osteotomy, adjuvant radiotherapy and chemotherapy (a case report).
    Theilen GH; Leighton R; Pool R; Park RD
    Vet Med Small Anim Clin; 1977 Feb; 72(2):179-83. PubMed ID: 265130
    [No Abstract]   [Full Text] [Related]  

  • 12. [New limb sparing therapy for osteosarcoma in the dog].
    Kirpensteijn J
    Tijdschr Diergeneeskd; 2005 Feb; 130(4):124. PubMed ID: 15754909
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the protective effects of all-trans-astaxanthin on canine osteosarcoma cell lines.
    Wakshlag JJ; Balkman CA; Morgan SK; McEntee MC
    Am J Vet Res; 2010 Jan; 71(1):89-96. PubMed ID: 20043787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamin D and retinoids on the differentiation and growth in vitro of canine osteosarcoma and its clonal cell lines.
    Barroga EF; Kadosawa T; Okumura M; Fujinaga T
    Res Vet Sci; 1999 Jun; 66(3):231-6. PubMed ID: 10333464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 gene mutations in canine osteosarcoma.
    Kirpensteijn J; Kik M; Teske E; Rutteman GR
    Vet Surg; 2008 Jul; 37(5):454-60. PubMed ID: 18986312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of 22-oxa-calcitriol and all- trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo.
    Barroga EF; Kadosawa T; Okumura M; Fujinaga T
    Res Vet Sci; 2000 Feb; 68(1):79-87. PubMed ID: 10684763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of isolated limb perfusion with cisplatin (CDDP) on canine osteosarcoma.
    Hoekstra HJ; Meutstege FJ; Oosterhuis JW; De Vries J; Schraffordt Koops H
    Cancer Treat Res; 1993; 62():245-9. PubMed ID: 8096740
    [No Abstract]   [Full Text] [Related]  

  • 18. Seeking enrolment for a new treatment for canine osteosarcoma.
    Polton G; Dunning M
    J Small Anim Pract; 2015 Jul; 56(7):481. PubMed ID: 26134604
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor necrosis following radiation therapy and/or chemotherapy for canine osteosarcoma.
    Withrow SJ; Powers BE; Straw RC; Thrall DE; Gillette EL; LaRue SM; Richter SL
    Chir Organi Mov; 1990; 75(1 Suppl):29-31. PubMed ID: 2249550
    [No Abstract]   [Full Text] [Related]  

  • 20. 17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines.
    Massimini M; Palmieri C; De Maria R; Romanucci M; Malatesta D; De Martinis M; Maniscalco L; Ciccarelli A; Ginaldi L; Buracco P; Bongiovanni L; Della Salda L
    Vet Pathol; 2017 May; 54(3):405-412. PubMed ID: 28438108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.